The predominant adverse reactions are gastrointestinal, affecting about 50% of users, and can include stomach discomfort, nausea, and a metallic taste in the mouth
The peptides interfere with each other's receptor occupancy, resulting in lower peak GH than either compound alone at optimal monotherapy dosing
But in clinical trials, it hasnt kept up with Lillys tirzepatide, much less retatrutide, although Novo Nordisk is testing higher doses
Lifestyle instructions should reinforce treatment goals
ROS acts as a central hub connecting ferroptosis to PCa pathogenesis, amplified by inflammatory signals and redox-sensitive transcription factors (e.g., Nrf2, HIF-1) that either directly enhance oxidative stress or indirectly modulate ferroptosis susceptibility [Figure 2A]